1 of 1
Story summary
- The PRIMA retinal implant, a tiny wireless device developed by Science Corporation, improved central vision in advanced age-related macular degeneration during a clinical trial.
- The trial involved 38 participants across five European countries.
- After one year, 81% of participants showed significant improvements in visual acuity, averaging 25 letters.
- Regulatory approvals are being sought for clinical use in Europe and the United States.
